Tirzepatide 50 mg – A Dual-Pathway Peptide for Precision Metabolic Studies

Tirzepatide 50mg from Leanify Med is a high-purity dual GIP and GLP-1 receptor agonist peptide formulated for metabolic and endocrinological research applications.

Engineered with a focus on sequence fidelity and molecular stability, Tirzepatide’s dual action allows researchers to analyze glucose regulation, insulin sensitivity, and lipid metabolism within integrated biological systems.

Each vial is produced in a GMP-certified facility, ensuring traceable raw materials, precision peptide synthesis, and HPLC/MS verification to confirm purity exceeding 99%. The compound is supplied as a lyophilized powder for extended shelf stability and controlled reconstitution.

Research Significance

Tirzepatide’s dual receptor agonism differentiates it from single-pathway analogs, allowing researchers to:

• Examine synergistic receptor signaling between GIP and GLP-1 pathways.
• Evaluate insulinotropic responses under controlled experimental conditions.
• Explore energy expenditure and nutrient partitioning mechanisms.
• Model metabolic syndrome and glucose dysregulation in preclinical settings.

These capabilities make Tirzepatide an indispensable molecule for investigating next-generation metabolic therapeutics.

Quality Assurance & Manufacturing Integrity

Leanify Med employs a multi-stage peptide purification process, integrating:

• Reverse-phase HPLC for removal of synthesis by-products.
• Mass spectrometry confirmation for sequence verification.
• Endotoxin screening for research safety assurance.
• Batch documentation and COA transparency for reproducibility.

Every vial is securely packaged and handled under sterile laboratory conditions to preserve molecular structure and integrity during transit.

Safety & Handling Precautions

• Product intended strictly for scientific research; not for human or veterinary consumption.
• Store in a temperature-controlled environment (-20°C recommended).
• Avoid multiple freeze-thaw cycles.
• Handle with standard laboratory PPE (gloves, lab coat, eye protection).

Frequently Asked Questions (FAQs)

Q1. What distinguishes Tirzepatide 50 mg from lower concentrations?
A: The 50mg format allows for broader experimental design flexibility and is ideal for institutions requiring scaled testing protocols or longitudinal study models.

Q2. What is the purity standard for Leanify Med’s Tirzepatide peptide?
A: Each batch is HPLC and Mass Spec validated to confirm ≥99% purity and sequence identity.

Q3. Can COAs be requested before purchase?
A: Yes, Certificates of Analysis are available upon request to verify molecular weight, composition, and batch compliance.

Q4. How long can the peptide be stored?
A: When maintained at -20°C, Tirzepatide 50 mg remains stable for up to 24 months in its lyophilized form.